TSBX(Delisted)
Turnstone BiologicsยทNASDAQ
--
--(--)
TSBX Profile
Turnstone Biologics Corp.
A clinical stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors
1110 North Virgil Avenue PMB 94659 , Los Angeles, California 90029
--
Turnstone Biologics Corp. was incorporated on December 13, 2018 under the laws of the State of Delaware. The company is a clinical-stage biotechnology company focused on developing new drugs to treat and cure patients with solid tumors. The approved immunotherapy represents a significant advance in the treatment of solid tumors, but many patients either do not respond or experience disease recurrence after an initial response. The company believes that the most significant challenge in creating therapeutic immunotherapies in these patients is the low number of T cells that can recognize and attack tumors, which the company calls tumor-reactive T cells. To solve this problem, the company is pioneering a differentiated approach for tumor-infiltrating lymphocytes (TILs).
